Intercept Pharmaceuticals Inc (ICPT) Insider Trading
- $40,838,442.32
- $758,937,384.01
- March 12, 2021
- David Shapiro
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 2, 2013 | CMO | 4,392 | $72.80 | Sell | $319,737.60 | |
| Sept. 20, 2013 | Insider | 2,000 | $61.07 | Sell | $122,140.00 | |
| Sept. 17, 2013 | CEO | 25,000 | $52.00 | Sell | $1,300,000.00 | |
| Sept. 13, 2013 | CEO | 12,500 | $49.02 | Sell | $612,750.00 | |
| Aug. 20, 2013 | Insider | 2,000 | $44.18 | Sell | $88,360.00 | |
| Aug. 16, 2013 | CMO | 5,016 | $49.20 | Sell | $246,787.20 | |
| Aug. 15, 2013 | CMO | 4,754 | $45.04 | Sell | $214,120.16 | |
| Aug. 12, 2013 | CEO | 12,500 | $45.98 | Sell | $574,750.00 | |
| Aug. 12, 2013 | Director | 4,759 | $46.13 | Sell | $219,532.67 | |
| July 22, 2013 | Insider | 2,000 | $49.44 | Sell | $98,880.00 | |
| July 15, 2013 | CEO | 25,000 | $50.05 | Sell | $1,251,250.00 | |
| July 9, 2013 | CEO | 37,500 | $46.36 | Sell | $1,738,500.00 | |
| July 8, 2013 | CFO | 25,000 | $45.39 | Sell | $1,134,750.00 | |
| July 2, 2013 | CMO | 4,369 | $43.63 | Sell | $190,619.47 | |
| June 26, 2013 | CEO | 12,500 | $40.06 | Sell | $500,750.00 | |
| June 20, 2013 | Insider | 2,000 | $37.07 | Sell | $74,140.00 | |
| June 20, 2013 | CEO | 25,000 | $38.25 | Sell | $956,250.00 | |
| June 19, 2013 | CFO | 50,575 | $34.50 | Sell | $1,744,837.50 | |
| June 17, 2013 | CMO | 5,016 | $32.72 | Sell | $164,123.52 | |
| May 28, 2013 | CFO | 6,225 | $34.50 | Sell | $214,762.50 | |
| May 20, 2013 | CFO | 28,200 | $34.50 | Sell | $972,900.00 | |
| May 16, 2013 | CMO | 5,016 | $31.31 | Sell | $157,050.96 | |
| April 9, 2013 | CMO | 3,750 | $34.41 | Sell | $129,037.50 | |
| Oct. 16, 2012 | Director | 333,334 | $15.00 | Buy | $5,000,010.00 |
Insiders are both buying and selling Intercept Pharmaceuticals Inc stock.
The insider traders at Intercept Pharmaceuticals Inc are: David Shapiro, Mark Pruzanski, Lisa Bright, Barbara Gayle Duncan, Luciano Adorini, Rachel Mcminn, Christian Weyer, Klaus R Dr Veitinger, Srinivas Akkaraju, Jonathan Silverstein, Orbimed Advisors Llc, Paolo Fundaro, David A Ford, Lorenzo Tallarigo, Nicole Williams, Sandip Kapadia, Jason Campagna, S.P.A. Genextra, Francesco Micheli, Richard J Kim, Daniel G Welch, Daniel Paul Regan, Ryan T Sullivan, Luca Benatti, Keith Michael Gottesdiener, Gail Cawkwell, and Klaus R. Dr Veitinger
The most active insider trader at Intercept Pharmaceuticals Inc is David Shapiro with 58 trades.
Orbimed Advisors Llc has sold the most Intercept Pharmaceuticals Inc stock with a total value of $229,892,319.98.
Francesco Micheli has bought the most Intercept Pharmaceuticals Inc stock with a total value of $50,000,000.00.
The most recent insider trade for Intercept Pharmaceuticals Inc was on March 12, 2021.
The single biggest insider buy for Intercept Pharmaceuticals Inc was from Francesco Micheli with a total value of $25,000,000.00 on April 9, 2018.
The single biggest insider sell for Intercept Pharmaceuticals Inc was from Lorenzo Tallarigo with a total value of $110,981,821.78 on April 10, 2014.